Oric Pharmaceuticals ORIC
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$450.4K (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 31.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has fallen from 17.74% to 10.35% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +360,000 | 2.3% |
| Zweig-DiMenna Associates, Inc. | Hedge Fund | 2026/Q3 | +268,790 | 0.3% |
| Morgan Stanley | Public Company | 2026/Q3 | +242,242 | 2.0% |
| Morgan Stanley Investment Management Inc. | Mutual Fund | 2026/Q3 | +242,242 | 2.0% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +1,535,826 | 1.5% |
| AIHC Capital Management Limited | Hedge Fund | 2026/Q3 | +1,368,909 | 3.7% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +1,229,771 | 6.4% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,191,804 | 4.7% |
| Algert Global LLC | Hedge Fund | 2026/Q3 | +1,078,943 | 1.2% |
| BlackRock | Mutual Fund | 2026/Q3 | +839,421 | 6.6% |
| Jones Hill Capital LP | Hedge Fund | 2026/Q3 | +747,313 | 0.7% |
| Adage Capital Management, L.P. | Hedge Fund | 2026/Q3 | +707,588 | 1.0% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +663,682 | 0.7% |
| Candriam, Société En Commandite Par Actions | Mutual Fund | 2026/Q3 | +605,683 | 1.1% |
| Two Sigma Investments, LP | Hedge Fund | 2026/Q3 | +603,664 | 0.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 19 Oct 2026 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -14,000 | $13.53 | 69,828 |
| 30 Sep 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Automatic Disposition | -3,200 | $12.91 | 241,772 |
| 30 Sep 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Derivative Exercise and Sale | -3,500 | $12.91 | 241,772 |
| 27 Sep 2026 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -13,400 | $13.53 | 69,828 |
| 23 Sep 2026 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -600 | $13.51 | 69,828 |
| 25 Aug 2026 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -77,000 | $13.69 | 69,828 |
| 23 Jul 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Open Market Disposition | -9,600 | $12.02 | 244,972 |
| 23 Jul 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Derivative Exercise and Sale | -3,500 | $12.02 | 244,972 |
| 5 Jul 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Automatic Disposition | -300 | $12.00 | 254,572 |
| 23 Feb 2026 | Dominic Piscitelli | Chief Financial Officer | Derivative Exercise and Sale | -52,000 | $13.51 | 68,148 |
| 15 Jan 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Automatic Disposition | -6,700 | $12.00 | 254,872 |
| 1 Jan 2026 | Pratik Multani | Chief Medical Officer | Other Derivative Acquisition | +35,500 | – | 35,500 |
| 1 Jan 2026 | Pratik Multani | Chief Medical Officer | Other Derivative Acquisition | +214,000 | $8.17 | 214,000 |
| 1 Jan 2026 | Angie You | Independent Director | Other Derivative Acquisition | +40,000 | $8.17 | 40,000 |
| 1 Jan 2026 | Richard Heyman | Founder, Independent Chairman & Member of Scientific Advisory Board | Other Derivative Acquisition | +40,000 | $8.17 | 40,000 |
| 1 Jan 2026 | Lori Kunkel | Independent Director | Other Derivative Acquisition | +40,000 | $8.17 | 40,000 |
| 1 Jan 2026 | Mardi Dier | Independent Director | Other Derivative Acquisition | +40,000 | $8.17 | 40,000 |
| 1 Jan 2026 | Jacob Chacko | Chief Executive Officer | Other Derivative Acquisition | +112,500 | – | 112,500 |
| 1 Jan 2026 | Jacob Chacko | Chief Executive Officer | Other Derivative Acquisition | +675,000 | $8.17 | 675,000 |
| 1 Jan 2026 | Steven Hoerter | Independent Director | Other Derivative Acquisition | +40,000 | $8.17 | 40,000 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 10,730,120 | 10.4% | 4.8 |
| 15 Oct 2026 | 15,422,384 | 14.9% | 10.5 |
| 30 Sep 2026 | 16,315,970 | 15.7% | 9.9 |
| 15 Sep 2026 | 17,532,473 | 16.9% | 14.2 |
| 31 Aug 2026 | 17,266,340 | 16.7% | 16.2 |
| 14 Aug 2026 | 18,392,742 | 17.7% | 11.0 |
No comments yet — be the first to weigh in on ORIC.
Sign in to join the discussion.